Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Sublingual Versus Vaginal Misoprostol for Induction of Labor for Primigravida at 41 or More Weeks of Pregnancy: A Randomized Clinical Trial
Conditions
Interventions
Misoprostol
Locations
1
Bhutan
Phuentsholing Hospital
Phuentsholing, Bhutan
Start Date
June 1, 2021
Primary Completion Date
November 30, 2021
Completion Date
November 30, 2021
Last Updated
May 17, 2021
Lead Sponsor
Ministry of Health, Bhutan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions